NO20071634L - Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner - Google Patents

Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner

Info

Publication number
NO20071634L
NO20071634L NO20071634A NO20071634A NO20071634L NO 20071634 L NO20071634 L NO 20071634L NO 20071634 A NO20071634 A NO 20071634A NO 20071634 A NO20071634 A NO 20071634A NO 20071634 L NO20071634 L NO 20071634L
Authority
NO
Norway
Prior art keywords
pyrid
pyrazolo
dihydro
ones
efficient synthesis
Prior art date
Application number
NO20071634A
Other languages
English (en)
Norwegian (no)
Inventor
Bang-Chi Chen
Boguslaw M Mudryk
Nicolas Cuniere
Dau-Ming Hsieh
Lucius Rossano
Jing Liang
Huiping Zhang
Rulin Zhao
Bei Wang
Adrian David
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20071634L publication Critical patent/NO20071634L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20071634A 2004-09-28 2007-03-28 Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner NO20071634L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61375404P 2004-09-28 2004-09-28
US63762304P 2004-12-20 2004-12-20
US11/235,647 US7304157B2 (en) 2004-09-28 2005-09-26 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
PCT/US2005/034511 WO2006036926A2 (en) 2004-09-28 2005-09-27 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Publications (1)

Publication Number Publication Date
NO20071634L true NO20071634L (no) 2007-06-21

Family

ID=36100112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071634A NO20071634L (no) 2004-09-28 2007-03-28 Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner

Country Status (11)

Country Link
US (3) US7304157B2 (enExample)
EP (1) EP1805176A2 (enExample)
JP (1) JP2008514710A (enExample)
KR (1) KR20070067176A (enExample)
AU (1) AU2005289598A1 (enExample)
BR (1) BRPI0516172A (enExample)
CA (1) CA2582222A1 (enExample)
IL (1) IL182147A0 (enExample)
MX (1) MX2007003427A (enExample)
NO (1) NO20071634L (enExample)
WO (1) WO2006036926A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331526B (en) * 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200738672A (en) * 2001-12-10 2007-10-16 Bristol Myers Squibb Co Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
DE60330749D1 (de) * 2002-01-21 2010-02-11 Organon Nv Verfahren zur herstellung von 7-alpha-methylsteroide
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) * 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
BRPI0519331A2 (pt) * 2004-12-15 2009-01-20 Bristol Myers Squibb Co formas cristalina de um inibidor de fator xa
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
CN105384739B (zh) * 2014-09-02 2020-03-20 石药集团中奇制药技术（石家庄）有限公司 吡唑并[3,4-c]吡啶类衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423698A (en) * 1994-03-30 1995-06-13 Molex Incorporated Electrical connector system for a video display tube yoke
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
HRP20080382A2 (en) 2001-09-21 2008-12-31 Bristol-Myers Squibb Company A Delaware (Usa) Corporation LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
TW200738672A (en) 2001-12-10 2007-10-16 Bristol Myers Squibb Co Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
US20060069085A1 (en) 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7396932B2 (en) * 2004-09-28 2008-07-08 Bristol-Myers Squibb Company Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US20060069260A1 (en) * 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones

Also Published As

Publication number Publication date
US20070282106A1 (en) 2007-12-06
WO2006036926A2 (en) 2006-04-06
WO2006036926B1 (en) 2007-03-15
US7435821B2 (en) 2008-10-14
EP1805176A2 (en) 2007-07-11
WO2006036926A3 (en) 2007-01-18
JP2008514710A (ja) 2008-05-08
US7579472B2 (en) 2009-08-25
US20060069119A1 (en) 2006-03-30
US20080009626A1 (en) 2008-01-10
CA2582222A1 (en) 2006-04-06
MX2007003427A (es) 2007-05-10
AU2005289598A1 (en) 2006-04-06
KR20070067176A (ko) 2007-06-27
US7304157B2 (en) 2007-12-04
BRPI0516172A (pt) 2008-08-26
IL182147A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
NO20071702L (no) Fremgangsmate for fremstilling av 4,5-dihydro-pyrazolo[3,4-C]pyrid-oner
NO20071707L (no) Fremstilling av 4,5-dihydro-pyrazolo[3,4-C]Pyrid-2-oner
NO20071634L (no) Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner
ZA200307450B (en) Process for the production of synthesis gas.
NO20072872L (no) Kjemisk prosess
WO2006058700A8 (en) Acetamide compounds as fungicides
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2002332140A1 (en) Process for reducing the toxicity of hydrocarbons
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
WO2005005461A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
AU2003263622A1 (en) Process for preparing prostaglandin derivatives and starting materials for the same
WO2005080403A3 (en) Chemical process
WO2005004606A3 (en) Pyridinylanilides
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
AU2003242867A1 (en) Process for the synthesis of mosapride
AU2003225426A1 (en) Process for the preparation of urea
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
AU2003293272A1 (en) Method for the production of bioprostheses
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
AU2003269482A1 (en) Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
DE60321724D1 (de) 1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application